Snapshot from May 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Bicara Therapeutics
Entity

Bicara Therapeutics

Tracked across 1 events · 40 articles · First seen May 05, 2026 · Last active May 05, 2026

Sentiment
60
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 60
Business
Biocon Names Claire Mazumdar Successor
Kiran Mazumdar-Shaw, the founder and chairperson of Biocon, has formally announced her niece, Claire Mazumdar, as her future successor. This move is part of Biocon's long-term leadership and succession planning strategy, aiming for a gradual…
Impact: Bicara Therapeutics, a Nasdaq-listed firm incubated by Biocon, is led by Claire Mazumdar and has seen its market capitalization exceed $1.6 billion under her leadership.
May 05, 2026 · 40 articles
Key Actions (1)
80 Claire Mazumdar led Bicara TherapeuticsBiocon Names Claire...
NEWSDESK
Track Bicara Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.